143 related articles for article (PubMed ID: 11124341)
1. Evaluation of microparticle enzyme immunoassay against HPLC-mass spectrometry for the determination of whole-blood tacrolimus in heart- and lung-transplant recipients.
Salm P; Rutherford DM; Taylor PJ; Black MJ; Pillans PI
Clin Biochem; 2000 Oct; 33(7):557-62. PubMed ID: 11124341
[TBL] [Abstract][Full Text] [Related]
2. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
Westley IS; Taylor PJ; Salm P; Morris RG
Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the tacrolimus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients.
Cogill JL; Taylor PJ; Westley IS; Morris RG; Lynch SV; Johnson AG
Clin Chem; 1998 Sep; 44(9):1942-6. PubMed ID: 9732981
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the reintroduced MEIA assay with HPLC-MS/MS for the determination of whole-blood sirolimus from transplant recipients.
Morris RG; Salm P; Taylor PJ; Wicks FA; Theodossi A
Ther Drug Monit; 2006 Apr; 28(2):164-8. PubMed ID: 16628125
[TBL] [Abstract][Full Text] [Related]
5. Is microparticle enzyme-linked immunoassay (MEIA) reliable for use in tacrolimus TDM? Comparison of MEIA to liquid chromatography with mass spectrometric detection using longitudinal trough samples from transplant recipients.
Napoli KL
Ther Drug Monit; 2006 Aug; 28(4):491-504. PubMed ID: 16885716
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of renal transplantation using liquid chromatographic monitoring of tacrolimus.
Borrows R; Chusney G; Loucaidou M; James A; Stichbury J; Van Tromp J; Cairns T; Griffith M; Hakim N; McLean A; Palmer A; Papalois V; Taube D
Ther Drug Monit; 2006 Apr; 28(2):269-73. PubMed ID: 16628143
[TBL] [Abstract][Full Text] [Related]
7. High-performance liquid chromatography-tandem mass spectrometry as a reference for analysis of tacrolimus to assess two immunoassays in patients with liver and renal transplants.
Salm P; Taylor PJ; Clark A; Balderson GA; Grygotis A; Norris RL; Lynch SV; Shaw LM; Pond SM
Ther Drug Monit; 1997 Dec; 19(6):694-700. PubMed ID: 9421113
[TBL] [Abstract][Full Text] [Related]
8. Modified pentamer formation assay for measurement of tacrolimus and its active metabolites: comparison with liquid chromatography-tandem mass spectrometry and microparticle enzyme-linked immunoassay (MEIA-II).
Armstrong VW; Schuetz E; Zhang Q; Groothuisen S; Scholz C; Shipkova M; Aboleneen H; Oellerich M
Clin Chem; 1998 Dec; 44(12):2516-23. PubMed ID: 9836720
[TBL] [Abstract][Full Text] [Related]
9. An immunoassay for the measurement of sirolimus.
Jones K; Saadat-Lajevard S; Lee T; Horwatt R; Hicks D; Johnston A; Holt DW
Clin Ther; 2000; 22 Suppl B():B49-61. PubMed ID: 10823373
[TBL] [Abstract][Full Text] [Related]
10. IMx tacrolimus II assay: is it reliable at low blood concentrations? A comparison with tandem MS/MS.
Ghoshal AK; Soldin SJ
Clin Biochem; 2002 Jul; 35(5):389-92. PubMed ID: 12270769
[TBL] [Abstract][Full Text] [Related]
11. The quantification of sirolimus by high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in renal transplant recipients.
Salm P; Taylor PJ; Pillans PI
Clin Ther; 2000; 22 Suppl B():B71-85. PubMed ID: 10823375
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic monitoring of tacrolimus concentrations in blood of renal and liver transplant recipients: comparison of microparticle enzyme immunoassay and enzyme multiplied immunoassay methods.
Bartlomiejczyk I; Zochowska D; Sanko-Resmer J; Matuszewicz D; Paczek L
Transplant Proc; 2006; 38(1):94-6. PubMed ID: 16504673
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus monitoring in renal transplantation: a comparison between high-performance liquid chromatography and immunoassay.
Borrows R; Chusney G; Loucaidou M; Singh S; James A; Stichbury J; Van Tromp J; Cairns T; Griffith M; Hakim N; McLean A; Palmer A; Papalois V; Taube D
Transplant Proc; 2005 May; 37(4):1733-5. PubMed ID: 15919448
[TBL] [Abstract][Full Text] [Related]
14. A specific method for the measurement of tacrolimus in human whole blood by liquid chromatography/tandem mass spectrometry.
Zhang Q; Simpson J; Aboleneen HI
Ther Drug Monit; 1997 Aug; 19(4):470-6. PubMed ID: 9263391
[TBL] [Abstract][Full Text] [Related]
15. Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods.
Akbas SH; Ozdem S; Caglar S; Tuncer M; Gurkan A; Yucetin L; Senol Y; Demirbas A; Gultekin M; Ersoy FF; Akaydin M
Clin Biochem; 2005 Jun; 38(6):552-7. PubMed ID: 15885236
[TBL] [Abstract][Full Text] [Related]
16. Effects of hematocrit value on microparticle enzyme immunoassay of tacrolimus concentration in therapeutic drug monitoring.
Tomita T; Homma M; Yuzawa K; Ohkohchi N; Hori T; Kaneko M; Hasegawa Y; Kojima H; Nagasawa T; Kohda Y
Ther Drug Monit; 2005 Feb; 27(1):94-7. PubMed ID: 15665753
[TBL] [Abstract][Full Text] [Related]
17. Low hematocrit and serum albumin concentrations underlie the overestimation of tacrolimus concentrations by microparticle enzyme immunoassay versus liquid chromatography-tandem mass spectrometry.
Brown NW; Gonde CE; Adams JE; Tredger JM
Clin Chem; 2005 Mar; 51(3):586-92. PubMed ID: 15650031
[TBL] [Abstract][Full Text] [Related]
18. Pitfalls in monitoring tacrolimus (FK 506).
Braun F; Schütz E; Christians U; Lorf T; Schiffmann JH; Armstrong VW; Schröter W; Sewing KF; Oellerich M; Ringe B
Ther Drug Monit; 1997 Dec; 19(6):628-31. PubMed ID: 9421102
[TBL] [Abstract][Full Text] [Related]
19. Determination of blood sirolimus concentrations in liver and kidney transplant recipients using the Innofluor fluorescence polarization immunoassay: comparison with the microparticle enzyme immunoassay and high-performance liquid chromatography-ultraviolet method.
Bouzas L; Hermida J; Tutor JC
Ups J Med Sci; 2009; 114(1):55-61. PubMed ID: 19242874
[TBL] [Abstract][Full Text] [Related]
20. Assessment of four methodologies (microparticle enzyme immunoassay, chemiluminescent enzyme immunoassay, affinity column-mediated immunoassay, and flow injection assay-tandem mass spectrometry) for measuring tacrolimus blood concentration in Japanese liver transplant recipients.
Hashi S; Masuda S; Kikuchi M; Uesugi M; Yano I; Omura T; Yonezawa A; Fujimoto Y; Ogawa K; Kaido T; Uemoto S; Matsubara K
Transplant Proc; 2014 Apr; 46(3):758-60. PubMed ID: 24767342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
